--- title: "Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)" type: "News" locale: "en" url: "https://longbridge.com/en/news/296266412.md" description: "On August 14, 2026, Cytokinetics, Incorporated (Nasdaq: CYTK) based in South San Francisco, granted stock options for 27,565 shares of common stock and 18,273 restricted stock units (RSUs) to 12 new employees who started in July and August 2026. The RSUs will be converted to common stock upon vesting. This action was taken as a significant incentive for their employment, totaling 45,838 equity units granted." datetime: "2026-08-18T20:01:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296266412.md) - [en](https://longbridge.com/en/news/296266412.md) - [zh-HK](https://longbridge.com/zh-HK/news/296266412.md) generator: "portal-rs" --- # Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) On August 14, 2026, Cytokinetics, Incorporated (Nasdaq: CYTK) based in South San Francisco, granted stock options for 27,565 shares of common stock and 18,273 restricted stock units (RSUs) to 12 new employees who started in July and August 2026. The RSUs will be converted to common stock upon vesting. This action was taken as a significant incentive for their employment, totaling 45,838 equity units granted. ### Related Stocks - [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md) ## Related News & Research - [Cytokinetics (CYTK) Shares In Focus After New Phase 3 Aficamten Data](https://longbridge.com/en/news/298814945.md) - [Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $264,110](https://longbridge.com/en/news/298363335.md) - [Cytokinetics director Robert E. Landry sells 1,000 common shares worth $74,660](https://longbridge.com/en/news/298775467.md) - [CYTK: MYQORZO drives growth with strong launches, robust pipeline, and expanding global reach](https://longbridge.com/en/news/298495700.md) - [Cytokinetics grants new-hire equity awards, stock options priced at $74.13 per share](https://longbridge.com/en/news/296264145.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**